181 related articles for article (PubMed ID: 25854612)
1. CRIT-LINE: a noninvasive tool to monitor hemoglobin levels in pediatric hemodialysis patients.
Garro R; Sutherland S; Bayes L; Alexander S; Wong C
Pediatr Nephrol; 2015 Jun; 30(6):991-8. PubMed ID: 25854612
[TBL] [Abstract][Full Text] [Related]
2. Using noninvasive hemoglobin measurements to estimate measured hemoglobin in a pediatric hemodialysis unit.
Stavinoha A; Modem V; Quigley R
Hemodial Int; 2013 Oct; 17 Suppl 1():S7-10. PubMed ID: 24134330
[TBL] [Abstract][Full Text] [Related]
3. Safety and usage of darbepoetin alfa in children with chronic kidney disease: prospective registry study.
Schaefer F; Hoppe B; Jungraithmayr T; Klaus G; Pape L; Farouk M; Addison J; Manamley N; Vondrak K
Pediatr Nephrol; 2016 Mar; 31(3):443-53. PubMed ID: 26482252
[TBL] [Abstract][Full Text] [Related]
4. Association between Severe Anemia and Outcomes of Hemodialysis Vascular Access.
Locham S; Mathlouthi A; Dakour-Aridi H; Nejim B; Malas MB
Ann Vasc Surg; 2020 Jan; 62():295-303. PubMed ID: 31449946
[TBL] [Abstract][Full Text] [Related]
5. Effect of variability in anemia management on hemoglobin outcomes in ESRD.
Lacson E; Ofsthun N; Lazarus JM
Am J Kidney Dis; 2003 Jan; 41(1):111-24. PubMed ID: 12500228
[TBL] [Abstract][Full Text] [Related]
6. Prediction of hemoglobin levels in individual hemodialysis patients by means of a mathematical model of erythropoiesis.
Fuertinger DH; Kappel F; Zhang H; Thijssen S; Kotanko P
PLoS One; 2018; 13(4):e0195918. PubMed ID: 29668766
[TBL] [Abstract][Full Text] [Related]
7. Determining optimum hemoglobin sampling for anemia management from every-treatment data.
Gaweda AE; Nathanson BH; Jacobs AA; Aronoff GR; Germain MJ; Brier ME
Clin J Am Soc Nephrol; 2010 Nov; 5(11):1939-45. PubMed ID: 20671221
[TBL] [Abstract][Full Text] [Related]
8. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
9. Time-averaged hemoglobin values, not hemoglobin cycling, have an impact on outcomes in pediatric dialysis patients.
Bakkaloğlu SA; Kandur Y; Serdaroğlu E; Noyan A; Bayazıt AK; Taşdemir M; Özlü SG; Özçelik G; Dursun İ; Alparslan C; Akcaboy M; Atikel YÖ; Parmaksız G; Atmış B; Sever L
Pediatr Nephrol; 2018 Nov; 33(11):2143-2150. PubMed ID: 30105415
[TBL] [Abstract][Full Text] [Related]
10. Using a non-invasive method in chronic hemodialysis pediatric patients to estimate hemoglobin.
Geer JJ; Braun MC; Srivaths PR
Pediatr Nephrol; 2015 Apr; 30(4):661-4. PubMed ID: 25322906
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting anemia management in hemodialysis patients: a single-center experience.
Spiegel DM; Gitlin M; Mayne T
Hemodial Int; 2008 Jul; 12(3):336-41. PubMed ID: 18638090
[TBL] [Abstract][Full Text] [Related]
12. Should asymptomatic patients discharged with lower hemoglobin expect worse outcomes after valve surgery?
Ad N; Holmes SD; Shuman DJ; Speir AM; Pritchard G; Halpin L
J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1322-8. PubMed ID: 26318009
[TBL] [Abstract][Full Text] [Related]
13. Dialysis patients with the metabolic syndrome need less recombinant human erythropoietin for similar hemoglobin levels.
Uyar ME; Tutal E; Bal Z; Sezer S
Transplant Proc; 2013; 45(10):3481-4. PubMed ID: 24314937
[TBL] [Abstract][Full Text] [Related]
14. Effect of darbepoetin alfa on renal anemia in Japanese hemodialysis patients.
Kusaba T; Ishida R; Nakayama M; Kato H; Uchiyama H; Sato K; Mori Y; Matsubara H; Kajita Y
Arzneimittelforschung; 2009; 59(9):435-9. PubMed ID: 19856789
[TBL] [Abstract][Full Text] [Related]
15. The health-related quality of life was not improved by targeting higher hemoglobin in the Normal Hematocrit Trial.
Coyne DW
Kidney Int; 2012 Jul; 82(2):235-41. PubMed ID: 22437411
[TBL] [Abstract][Full Text] [Related]
16. Association of hemoglobin variability and mortality among contemporary incident hemodialysis patients.
Brunelli SM; Lynch KE; Ankers ED; Joffe MM; Yang W; Thadhani RI; Feldman HI
Clin J Am Soc Nephrol; 2008 Nov; 3(6):1733-40. PubMed ID: 18922985
[TBL] [Abstract][Full Text] [Related]
17. Cost savings using a protocol approach to manage anemia in a hemodialysis unit.
Charlesworth EC; Richardson RM; Battistella M
Am J Nephrol; 2014; 39(6):509-14. PubMed ID: 24903565
[TBL] [Abstract][Full Text] [Related]
18. Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients.
Penne EL; van der Weerd NC; Grooteman MP; Mazairac AH; van den Dorpel MA; Nubé MJ; Bots ML; Lévesque R; ter Wee PM; Blankestijn PJ;
Clin J Am Soc Nephrol; 2011 Feb; 6(2):281-9. PubMed ID: 21030579
[TBL] [Abstract][Full Text] [Related]
19. Characterization of hepatic and cardiac iron deposition during standard treatment of anaemia in haemodialysis.
Holman R; Olynyk JK; Kulkarni H; Ferrari P
Nephrology (Carlton); 2017 Feb; 22(2):114-117. PubMed ID: 26824431
[TBL] [Abstract][Full Text] [Related]
20. Association of a change in erythropoiesis-stimulating agent dose during hospitalization and subsequent hemoglobin levels and transfusions in hemodialysis patients.
Wong BC; Ravani P; Manns BJ; Lewin A; Zhang X; Chin R; Hemmelgarn BR; Tonelli M; Oliver MJ; Quinn RR
Am J Kidney Dis; 2013 Nov; 62(5):947-52. PubMed ID: 23856380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
